AGP Executive Report
Last update: 7 hours agoHemp Policy Fight: Montana hemp processors say a U.S. Senate delay on a planned hemp ban is a “huge win,” buying time after concerns about potent hemp products reaching kids. Public Health & Safety: A pediatrician/ neuroscientist op-ed argues Congress must close the “intoxicating hemp” loophole for delta-8-style products sold like candy, pushing for stronger oversight and age protections. Clinical Research: A new clinical trial report claims oral CBD can ease post-surgery ocular pain as effectively as opioids. Market & Regulation: Texas THC product rules remain in flux as lawsuits and enforcement actions keep reshaping what’s on shelves. Criminal Justice: China prosecutors say two foreign transit passengers pleaded guilty after being caught with 70 kg of cannabis at Beijing airport, despite “in transit” claims. Industry Expansion: Argent BioPharma is pushing into the U.S. with medicinal cannabis therapy for dogs with cancer. Community & Care: A Massachusetts crackdown on kratom continues with emergency orders targeting products.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.